[1] Tang YY, Zhou LN, Wang F, et al. Assessing the efficiency of eligibility criteria for low-dose computed tomography lung screening in China according to current guidelines. BMC Med, 2024; 22, 267. doi:  10.1186/s12916-024-03445-5
[2] Miao XX, Su YP, Hou CS, et al. Indoor radon survey in 31 provincial capital cities and estimation of lung cancer risk in urban areas of China. Biomed Environ Sci, 2024; 37, 1294−302.
[3] Hu WQ, Zhou WG, Zhou GW, et al. A comprehensive study of the association between LEPR gene rs1137101 variant and risk of digestive system cancers. Biomed Environ Sci, 2024; 37, 445−56.
[4] Wang F, Tan FW, Shen SP, et al. Risk-stratified approach for never- and ever-smokers in lung cancer screening: a prospective cohort study in China. Am J Respir Crit Care Med, 2023; 207, 77−88. doi:  10.1164/rccm.202204-0727OC
[5] Su Y, Zhan HR, Li SY, et al. Development and validation of machine learning models for lung cancer risk prediction in high-risk population: a retrospective cohort study. Biomed Environ Sci, 2025; 38, 501-5.
[6] Tian JB, Zhang M, Zhang FW, et al. Developing an optimal stratification model for colorectal cancer screening and reducing racial disparities in multi-center population-based studies. Genome Med, 2024; 16, 81. doi:  10.1186/s13073-024-01355-y
[7] Jayasekera J, Mandelblatt JS. Systematic review of the cost effectiveness of breast cancer prevention, screening, and treatment interventions. J Clin Oncol, 2020; 38, 332−50.
[8] Hill H, Roadevin C, Duffy S, et al. Cost-effectiveness of AI for risk-stratified breast cancer screening. JAMA Netw Open, 2024; 7, e2431715. doi:  10.1001/jamanetworkopen.2024.31715
[9] Wong JZY, Chai JH, Yeoh YS, et al. Cost effectiveness analysis of a polygenic risk tailored breast cancer screening programme in Singapore. BMC Health Serv Res, 2021; 21, 379. doi:  10.1186/s12913-021-06396-2
[10] National Health Commission of the People’s Republic of China, National Development and Reform Commission, Ministry of Education of the People’s Republic of China, et al. Notice on the issuance of the healthy China action - cancer prevention and control action implementation plan (2023-2030). http://www.nhc.gov.cn/ylyjs/pqt/202311/18bd5bb5abc74ebc896f9d5c9ca63422.shtml. [2025-04-27]. (In Chinese)
[11] Wang F, Dong XS, Li N. A call to improve the quality of screening programs. Nat Med, 2023; 29, 1062−3. doi:  10.1038/s41591-023-02305-8
[12] Li CC, Cheng B, Li JF, et al. Non-risk-based lung cancer screening with low-dose computed tomography. JAMA 2025; e254017.